These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3032089)

  • 41. Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
    Sutton D; Boyd MR
    Antimicrob Agents Chemother; 1993 Apr; 37(4):642-5. PubMed ID: 8388195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
    Bernstein DI; Ireland J; Bourne N
    Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
    Reefschläger J; Wutzler P; Thiel KD; Herrmann G
    Antiviral Res; 1986 Mar; 6(2):83-93. PubMed ID: 3010858
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.
    Nugier F; Colin JN; Aymard M; Langlois M
    J Med Virol; 1992 Jan; 36(1):1-12. PubMed ID: 1315366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent.
    Mansuri MM; Ghazzouli I; Chen MS; Howell HG; Brodfuehrer PR; Benigni DA; Martin JC
    J Med Chem; 1987 May; 30(5):867-71. PubMed ID: 3033244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity.
    Schwartz PM; Novack J; Shipman C; Drach JC
    Biochem Pharmacol; 1984 Aug; 33(15):2431-8. PubMed ID: 6087827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
    Ljungman P; Ellis MN; Hackman RC; Shepp DH; Meyers JD
    J Infect Dis; 1990 Jul; 162(1):244-8. PubMed ID: 2162368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
    Spruance SL; Freeman DJ; Sheth NV
    Antimicrob Agents Chemother; 1986 Jul; 30(1):196-8. PubMed ID: 2944480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
    Bastow KF; Derse DD; Cheng YC
    Antimicrob Agents Chemother; 1983 Jun; 23(6):914-7. PubMed ID: 6311091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus].
    Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS
    Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
    Balfour HH; Benson C; Braun J; Cassens B; Erice A; Friedman-Kien A; Klein T; Polsky B; Safrin S
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):254-60. PubMed ID: 8106965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.
    Lee PH; Su MH; Kern ER; Higuchi WI
    Pharm Res; 1992 Aug; 9(8):979-89. PubMed ID: 1329068
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of acyclovir-resistant and -sensitive herpes simplex viruses isolated from a patient with an acquired immune deficiency.
    Schinazi RF; del Bene V; Scott RT; Dudley-Thorpe JB
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():127-34. PubMed ID: 3025153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
    Nitta K; Shiota H; Naito T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
    Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
    Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
    Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
    J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activity of ketoconazole against herpes simplex virus.
    Pottage JC; Kessler HA; Goodrich JM; Chase R; Benson CA; Kapell K; Levin S
    Antimicrob Agents Chemother; 1986 Aug; 30(2):215-9. PubMed ID: 3021048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.
    Kim JH; Schaenman JM; Ho DY; Brown JM
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
    Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.